Diuretic and natriuretic properties of fenoldopam in chronic renal failure

J Hypertens Suppl. 1989 Dec;7(6):S326-7. doi: 10.1097/00004872-198900076-00159.

Abstract

The effect of intravenously administered fenoldopam on diuresis and natriuresis was investigated in a group of 10 patients with advanced chronic renal failure. After an initial basal period of 1 h, a fenoldopam infusion was started and maintained for 12 h at rates varying between 0.025 and 0.1 microgram/kg per min. During the study, blood pressure was measured every 10 min and urine volume, natriuresis and creatinine clearance were measured hourly. Fenoldopam induced a significant increase in urine volume, natriuresis and creatinine clearance (P less than 0.05-0.001) accompanied by a small but significant drop in blood pressure (P less than 0.05-0.01). These results show that for advanced chronic renal failure, fenoldopam has diuretic and natriuretic properties that could be of clinical relevance.

MeSH terms

  • 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine / analogs & derivatives*
  • 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine / therapeutic use
  • Blood Pressure / drug effects
  • Blood Pressure / physiology
  • Diuresis / drug effects*
  • Diuresis / physiology
  • Dopamine Agents / therapeutic use*
  • Dose-Response Relationship, Drug
  • Drug Evaluation
  • Fenoldopam
  • Humans
  • Kidney Failure, Chronic / drug therapy*
  • Kidney Failure, Chronic / physiopathology
  • Natriuresis / drug effects*
  • Natriuresis / physiology

Substances

  • Dopamine Agents
  • 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine
  • Fenoldopam